(Q35480437)

8 August 2017

1 reference

title

Respiratory syncytial virus infections. (English)

1 reference

8 August 2017

M I Marks

1

1 reference

8 August 2017

publication date

1 November 1992

1 reference

8 August 2017

1 reference

8 August 2017

volume

31

1 reference

8 August 2017

issue

11

1 reference

8 August 2017

page(s)

688-691

1 reference

Acute respiratory infections in children: etiology and epidemiology

8 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1177%2F000992289203101109

Multicenter study of strains of respiratory syncytial virus

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F000992289203101109

From the National Institute of Allergy and Infectious Diseases and the World Health Organization. Respiratory syncytial and parainfluenza viruses

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F000992289203101109

An epidemic of respiratory syncytial virus in elderly people: clinical and serological findings

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F000992289203101109

Association between respiratory syncytial virus outbreaks and lower respiratory tract deaths of infants and young children

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F000992289203101109

Immunity to and frequency of reinfection with respiratory syncytial virus

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F000992289203101109

Predictive value of respiratory syncytial virus-specific IgE responses for recurrent wheezing following bronchiolitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F000992289203101109

Role of respiratory syncytial virus in early hospitalizations for respiratory distress of young infants with cystic fibrosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F000992289203101109

Respiratory syncytial virus infection in human immunodeficiency virus-infected children

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F000992289203101109

Respiratory syncytial virus (RSV) infection rate in personnel caring for children with RSV infections. Routine isolation procedure vs routine procedure supplemented by use of masks and goggles

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F000992289203101109

Prevention of nosocomial respiratory syncytial virus infections through compliance with glove and gown isolation precautions

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F000992289203101109

Screening for respiratory syncytial virus and assignment to a cohort at admission to reduce nosocomial transmission

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F000992289203101109

Vapors, viruses, and views. Ribavirin and respiratory syncytial virus

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F000992289203101109

Economic and long-term benefits of ribavirin therapy on respiratory syncytial virus infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F000992289203101109

Aerosolized ribavirin treatment of infants with respiratory syncytial viral infection. A randomized double-blind study

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F000992289203101109

Early ribavirin treatment of respiratory syncytial viral infection in high-risk children

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F000992289203101109

Comparative inhibition of influenza and parainfluenza virus replication by ribavirin in MDCK cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F000992289203101109

Ribavirin Aerosol Treatment of Influenza B Virus Infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F000992289203101109

Treatment of influenza A (H1N1) virus infection with ribavirin aerosol

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F000992289203101109

Oral ribavirin treatment of influenza A and B.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F000992289203101109

Plasma disappearance, urine excretion, and tissue distribution of ribavirin in rats and rhesus monkeys

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F000992289203101109

High-dose, short-duration ribavirin aerosol therapy in children with suspected respiratory syncytial virus infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F000992289203101109

A controlled trial of aerosolized ribavirin in infants receiving mechanical ventilation for severe respiratory syncytial virus infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F000992289203101109

Intravenous immunoglobulin treatment of respiratory syncytial virus infections in infants and young children

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F000992289203101109

Effect of ribavirin therapy on respiratory syncytial virus-specific IgE and IgA responses after infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F000992289203101109

Ribavirin treatment of viral pneumonitis in severe combined immunodeficiency disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F000992289203101109

Embryotoxic, teratogenic, and metabolic effects of ribavirin in mice.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F000992289203101109

Inhibitory effects of antiviral compounds on respiratory syncytial virus replication in vitro

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F000992289203101109

Evaluation of the toxicity and antiviral activity of carbocyclic 3-deazaadenosine against respiratory syncytial and parainfluenza type 3 viruses in tissue culture and in cotton rats

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F000992289203101109

Use of intravenous gamma globulin to passively immunize high-risk children against respiratory syncytial virus: safety and pharmacokinetics. The RSVIG Study Group

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F000992289203101109

Immunization of cotton rats with the fusion (F) and large (G) glycoproteins of respiratory syncytial virus (RSV) protects against RSV challenge without potentiating RSV disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F000992289203101109

10.1177/000992289203101109

21 January 2018

Identifiers

DOI

0 references

1 reference